This is a pilot study enrolling adult hemodialysis patients with diabetes recruited from the University of California Irvine Medical Center (UCIMC) who will undergo simultaneous measurement of glucose levels using 1) continuous glucose monitor (CGM) measured by a Dexcom G6 device vs. 2) "gold-standard" blood glucose levels using capillary fingerstick or venous blood glucose measurements obtained on a point of care (POC) blood glucose meter. The study will assess Dexcom G6 accuracy by comparing glucose levels on the CGM device vs. blood glucose measurements in the study population.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
30
Eligible patients will undergo DDexcom G6 Continuous Glucose Monitor device placement
University of California Irvine
Orange, California, United States
Blood glucose measurement
Proportion of CGM values within 20% of blood glucose levels \>100 mg/dl or within 20 mg/dl of blood glucose level for levels \<=100 mg/dl. (Will examine different thresholds of CGM values within a certain range of blood glucose levels, i.e., 10%, 15%, 25%.)
Time frame: 3 to 5 days
Hypoglycemia events
Comparison in number of hypoglycemia events (glucose \<70 mg/dl) determined by CGM or by blood glucose measurements
Time frame: 3 to 5 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.